Edwards Lifesciences is backing out of its plan to acquire JenaValve. The move comes after the Federal Trade Commission won a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback